Cargando…

Androgen Receptor: A Complex Therapeutic Target for Breast Cancer

Molecular and histopathological profiling have classified breast cancer into multiple sub-types empowering precision treatment. Although estrogen receptor (ER) and human epidermal growth factor receptor (HER2) are the mainstay therapeutic targets in breast cancer, the androgen receptor (AR) is evolv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanan, Ramesh, Dalton, James T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187506/ https://www.ncbi.nlm.nih.gov/pubmed/27918430 http://dx.doi.org/10.3390/cancers8120108

Ejemplares similares

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Selective androgen receptor modulators in preclinical and clinical development
por: Narayanan, Ramesh, et al.
Publicado: (2008)

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
por: Mohler, Michael L., et al.
Publicado: (2021)

Androgen receptor function and targeted therapeutics across breast cancer subtypes
por: Kolyvas, Emily A., et al.
Publicado: (2022)

Androgen receptor in bladder cancer: A promising therapeutic target
por: Tripathi, Abhishek, et al.
Publicado: (2020)

Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
por: Narayanan, Ramesh, et al.
Publicado: (2014)

Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
por: Stella, Stefania, et al.
Publicado: (2023)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

The importance of androgen receptors in breast cancer
por: Niţă, Irina, et al.
Publicado: (2021)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
por: Mina, Alain, et al.
Publicado: (2017)

Therapeutic androgen receptor ligands
por: Allan, George F., et al.
Publicado: (2003)

Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
por: Chung, Wei-Min, et al.
Publicado: (2021)

The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
por: Li, Liuxun, et al.
Publicado: (2022)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Androgen receptor as potential therapeutic target in metastatic endometrial cancer
por: Tangen, Ingvild Løberg, et al.
Publicado: (2016)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

Androgen Receptor as a Potential Target for Treatment of Breast Cancer
por: Wu, Y, et al.
Publicado: (2016)

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
por: You, Chan-Ping, et al.
Publicado: (2022)

Modulating the Activity of Androgen Receptor for Treating Breast Cancer
por: You, Chan-Ping, et al.
Publicado: (2022)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Androgen receptor: a potential therapeutic target for glioblastoma
por: Zalcman, Nomi, et al.
Publicado: (2018)

The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018)

Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
por: Jinna, Nikita, et al.
Publicado: (2022)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
por: Hamilton, Nalo, et al.
Publicado: (2017)

Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention
por: Dahiya, Ujjwal R., et al.
Publicado: (2022)

Post-menopausal breast cancer: from estrogen to androgen receptor
por: Majumder, Avisek, et al.
Publicado: (2017)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
por: Narayanan, Ramesh, et al.
Publicado: (2010)

The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
por: Di Donato, Marzia, et al.
Publicado: (2021)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers
por: Ulm, Michael, et al.
Publicado: (2019)

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
por: He, Licai, et al.
Publicado: (2017)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism
por: Coss, Christopher C, et al.
Publicado: (2014)

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
por: Asim, Mohammad, et al.
Publicado: (2015)

Targeting androgen receptor signaling with MicroRNAs and Curcumin: a promising therapeutic approach for Prostate Cancer Prevention and intervention
por: Javed, Zeeshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i63d4b9o0j6kcacb7627jk2mcn